In 2003, the antibiotic 'Factive', the first new domestic drug, was approved by the U.S
nejm.org/doi/full/10.10 CagrilintideSemaglutide in Adults with Overweight or Obesity and Type 2 Diabetes | New England Journal of Medicine @NEJM #ADA2025 nejm.org/doi/full/10.10 CagrilintideSemaglutide in Adults with Overweight or Obesity and Type 2 Diabetes | New England Journal of Medicine @NEJM #ADA2025
There is also debate as to the best delivery system, whether liposomal, oral, or intravenous
In fact, although more studies are required to increase the selectivity of these anticancer ROS-related drugs, the common mechanisms elicited by oncogenes to promote the adaptation to a large set of stress conditions are being revealed in more depth every day, and in a high percentage, they concern the redox balance
What is the half-life of BPC-157